In this episode of The Dr. Hyman Show, Dr. Mark Hyman interviews Dr. Nolan Williams, a neuropsychiatrist from Stanford's Brain Stimulation Lab, about the potential of ibogaine, a psychedelic compound derived from an African root bark, in treating mental health disorders. They discuss ibogaine's unique mechanisms of action, including its broad interaction with neurotransmitter systems and its ability to promote a neutral, third-party perspective on traumatic memories. The conversation covers ibogaine's potential applications for addiction, PTSD, depression, and traumatic brain injury, as well as its effects on brain structure and function, such as slowing brainwave activity and potentially reversing brain age. They also address the challenges and risks associated with ibogaine research and use, including its cardiac risks and regulatory hurdles, while highlighting its potential as a paradigm-shifting treatment in psychiatry.
Sign in to continue reading, translating and more.
Continue